Premium
Progestin challenge test in postmenopausal patients
Author(s) -
Valenzuela P.,
Sabatel R.M.,
Valls V.,
Nieto A.,
GonzalezGomez F.
Publication year - 1993
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(93)90521-w
Subject(s) - progestin , medicine , bleed , endometrial cancer , postmenopausal women , overweight , menopause , hormone therapy , gynecology , test (biology) , cancer , obstetrics , hormone , breast cancer , obesity , surgery , paleontology , biology
OBJECTIVES: The purpose of this study is to analyze the characteristics of patients identified with the progestin test. METHODS: We administered the progestin challenge test to 157 postmenopausal women and compared the characteristics of the patients who bled, with those who did not. RESULTS: Bleeding occurred in 14.01% of cases and we found that the number of patients who bled were significantly and independently more overweight, had higher levels of plasma estradiol, had a clear presence of superficial cells in the vaginal epithelium and had been menopausal for fewer years than those who did not bleed. CONCLUSIONS: We concluded that the test identifies women at risk from hormone‐related endometrial cancer.